![4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid](https://static.cymitquimica.com/products/3D/img/NAA18287.png "Cliccare per ingrandire")
4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid
CAS: 13182-87-1
Rif. 3D-NAA18287
| 5g | Prezzo su richiesta | ||
| 10g | Prezzo su richiesta |
Informazioni sul prodotto
- 4-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid
- Butanedioic acid, 1-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl] ester
- Butanedioic acid, mono(2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl) ester
- Imidazole-1-ethanol, 2-methyl-5-nitro-, hydrogen succinate (ester)
- Metronidazole hemisuccinate
- Metronidazole hydrogen succinate
- Metronidazole monosuccinate
- Succinic acid, 2-(2-methyl-5-nitroimidazol-1-yl)ethyl ester
- Succinic acid, mono[2-(2-methyl-5-nitroimidazol-1-yl)ethyl] ester
4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid is a nitroimidazole that has been shown to be effective in the treatment of cancer. It inhibits cancer by interfering with the synthesis of DNA, leading to cell death. 4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid can also inhibit bacterial growth and kill bacteria through the production of reactive oxygen species. This drug has been shown to produce genotoxic impurities in laboratory animals, which may lead to mutations and cancer. The structure of 4-[2-(2methyl 5 nitro 1 H imidazol 1 yl)ethoxy]4 oxobutanoic acid is characterized by a pyrazole ring with two methyl substituents on the nitrogen
Proprietà chimiche
Richiesta tecnica su: 3D-NAA18287 4-[2-(2-Methyl-5-nitro-1H-imidazol-1-yl)ethoxy]-4-oxobutanoic acid
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
